US: SCOTUS to rule on weight of Chinese government evidence after vitamin C case
On Friday, January 12, the Supreme Court said it would hear an antitrust case involving price fixing by Chinese vitamin C makers, agreeing to decide whether US judges must defer to legal submissions made by the Chinese government.
The case goes back to 2005 when a lawsuit brought by vitamin C purchasers alleged that Chinese vitamin C makers were conspiring to fix prices and supplies in the US.
In a twist, the Chinese companies did not refute the allegations but instead insisted that their actions were required under Chinese regulations that directly address vitamin C export pricing.
Furthermore, China’s Ministry of Commerce moved to aid the Chinese vitamin C makers by filing a friend-of-the-court brief that urged dismissal of the lawsuit explaining that the companies’ actions were mandated by Chinese law and argued the lawsuit was an inappropriate interference with Chinese industrial policy.
In 2013, a Brooklyn court sided with the US vitamin purchasers, but in 2016 the Second US Circuit Court of Appeals in New York sided with the Chinese companies.
Now, the Supreme Court will review the case.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI